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In Brief Puchalska et al. combine stable isotope tracing with untargeted metabolomics to identify the specific roles of the ketone bodies, acetoacetate (AcAc) and Db-hydroxybutyrate (D-bOHB), in mediating metabolic plasticity in macrophages. They unveil a hepatocytemacrophage ketone shuttle and show that AcAc protects the liver from high-fatdiet-induced fibrosis.
INTRODUCTION
Ketone bodies are an alternative source of metabolic energy, especially during states of diminished carbohydrate availability (McGarry and Foster, 1980; Robinson and Williamson, 1980) . Ketones are generated from fatty acid-derived acetyl-coenzyme A (CoA) through a series of reactions requiring the fate committing mitochondrial 3-hydroxymethylglutaryl (HMG)-CoA synthase (HMGCS2) expressed in hepatocytes and gut epithelial cells. Acetoacetate (AcAc) represents 25%-50% of the total ketone body pool produced by the liver, with the balance secreted as its reduced form D-b-hydroxybutyrate (D-bOHB), produced by mitochondrial D-bOHB dehydrogenase (BDH1) (Krebs and Hems, 1970; McGarry and Foster, 1971) . Robust ketogenesis is relatively restricted to hepatocytes due to abundant HMGCS2 expression. After ketones are released from hepatocytes into the circulation, D-bOHB is oxidized to AcAc in mitochondria of extrahepatic cells via BDH1, and a CoA moiety is transferred from succinyl-CoA to AcAc via SCOT (succinyl-CoA-oxoacid transferase, encoded by the Oxct1 gene), which prepares AcAc for terminal oxidation. SCOT's ubiquitous expression is excluded from hepatocytes, preventing ketone oxidation in these cells. While numerous metabolic pathways, such as b-oxidation, the tricarboxylic acid (TCA) cycle, and gluconeogenesis intersect with ketone body metabolism, the only known physiologically relevant metabolic fate of ketone bodies is their SCOT-dependent terminal oxidation in the TCA cycle. Multiple studies suggest diverse signaling roles for ketones, even in carbohydrate replete states, a subset of which could be independent of their metabolism (Puchalska and Crawford, 2017) . For example, bOHB inhibits the NLRP3 inflammasome in macrophages and has neuroprotective effects on macrophages that may require signaling through the G protein coupled receptor GPR109A (Rahman et al., 2014; Youm et al., 2015) .
Macrophage phenotypes in mammalian tissues exhibit marked metabolic plasticity, depending on cell ontogeny, tissue localization, and environmental stimuli (Puleston et al., 2017; Saha et al., 2017) . Phenotypic features of classically polarized inflammatory (M1) and alternatively polarized reparative (M2) macrophages helps to orient the wide spectrum of macrophage populations and functions (Kelly and O'Neill, 2015) . The classically polarized phenotype is associated with tissue injury and inflammatory signaling and is triggered by pathogen-associated mediators such as lipopolysaccharides (LPSs) (Martinez and Gordon, 2014) . The alternatively polarized phenotype antagonizes the inflammatory response, favoring tissue repair, remodeling, and fibrosis, and is triggered by activation of the IL-4/ STAT6-dependent pathway (Minutti et al., 2017) . Classically polarized macrophages employ glycolysis and the pentose phosphate pathway (PPP) to support microbicidal functions, whereas alternatively polarized macrophages leverage fatty acid oxidation for metabolic demands (Vats et al., 2006; Xu et al., 2015) . Recent observations raise questions regarding the roles of metabolic fuels in macrophage function and whether all fuels are handled equivalently by polarized macrophages (Gonzalez-Hurtado et al., 2017; Nomura et al., 2016) . Oxidation of alternative metabolic fuels such as ketones has been relatively unexplored in macrophages, although SCOT is abundantly expressed in bone marrow-derived macrophages (BMDMs) (Youm et al., 2015) . To determine the roles of ketone body metabolism in macrophages, we developed a stable isotope tracing untargeted metabolomics (ITUM) pipeline utilizing liquid chromatography (LC)/high-accuracy mass spectrometry (MS). Until now, the utilization of stable isotopes has largely been confined either to differential distribution of label through known substrate-product relationships or to quantify canonical fluxes performed in stationary or non-stationary analysis. The convergence of stable isotope labels with untargeted metabolomics approaches until now has not been applied in disease-relevant contexts (also in Puchalska et al., 2018) . We used cultured primary BMDMs to discover a set of mitochondrial and cytoplasmic metabolic pathways to which AcAc, but not bOHB, can contribute, many of which are shared with glucose-utilizing networks. Use of SCOT-deficient macrophages revealed mitochondrial metabolism as the predominant route. Loss of SCOT in hepatic tissue macrophages, lobular neighbors to ketone-and glucose-producing hepatocytes, predisposed mice to an exuberant fibrotic hepatic phenotype. These findings reveal a ketone shuttle between hepatocytes and local macrophages that modulates the liver's fibrotic response to increased fat ingestion and supports the notion that metabolism of the two ketone bodies AcAc and bOHB have segregated roles in macrophage biology.
RESULTS

Macrophages Oxidize AcAc, but Not bOHB
To study the metabolic fates of ketone bodies in macrophages, we cultured primary BMDMs and first confirmed phenotypic responses to stimulants of the classic (Tnfa gene, induced by LPS) and alternative (Arg1 gene, induced by IL-4) polarization phenotypes (Figures S1A and S1B) . To quantitatively determine the metabolic transformations of [ 13 
C]AcAc or D-[
13 C]bOHB in BMDMs, we applied ITUM, and analyzed the data with X 13 CMS (Huang et al., 2014) . This analytical platform sorts features (pairs of m/z and retention time) into isotopologue groups of putatively labeled metabolites and calculates the relative isotopic enrichment for each member. We tested ketone bodies at 1 mM, a concentration high enough to reveal cellular oxidation but still lower than achieved through starvation or ketogenic diets (Robinson and Williamson, 1980; Wildenhoff et al., 1974) . After treatment for 6 or 24 hr of BMDM with 1 mM [U- 13 C 4 ]AcAc, we observed up to 50% fractional 13 C enrichment of TCA cycle intermediates ( Figures 1A, S1C , and S1D). Among polarized macrophage states, fractional 13 C enrichments of glutamate (a reporter of a-ketoglutarate) and malate were decreased by $25% (p < 0.001) in LPS polarized macrophages, compared with unpolarized and IL-4-polarized BMDMs (Figure 1A) . In contrast to AcAc, 1 mM D-[U- 13 C 4 ]bOHB did not produce any 13 C labeling of TCA cycle intermediates in macrophages (Figure 1B) , despite its avid uptake into these cells (Figure S1E ). To become accessible for terminal oxidation, D-bOHB first requires NAD + -dependent oxidation to AcAc by mitochondrial BDH1, whose DG favors D-bOHB formation, and is sensitive to the mitochondrial NAD + /NADH ratio (Krebs et al., 1969; Williamson et al., 1967 ) (Figure 1C Figure 1E ). To confirm the absence of mitochondrial BDH activity in BMDMs, we increased the mitochondrial NAD + /NADH ratio by treatment with the ionophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) (0.5-2 mM) for 6 hr. Under these conditions, which favor D-bOHB oxidation to AcAc, [ 13 C]bOHB also did not enrich TCA cycle pools (Figure 1F ). Thus, irrespective of polarization state, BMDMs selectively oxidize AcAc but not D-bOHB. To the best of our knowledge, our data report for the first time impaired BDH1 expression in extrahepatic cells and selective utilization of ketone body redox partners.
AcAc Metabolism Converges with Non-oxidative Pathways in Macrophages
To determine whether macrophages allocate metabolites of [ 13 C]AcAc beyond TCA cycle intermediates, we used X 13 CMS to interrogate datasets derived from BMDMs cultured in 1 mM [ 13 C]AcAc for 24 hr. The results were analyzed using the pipeline schematized in Figure 2A . In this approach, each labeled sample is compared with control unlabeled samples prepared under identical conditions, conferring datasets revealing increased abundances of 13 C isotopologues of identical metabolites, rather than increased abundances of alternative metabolites. We retrieved 187, 162, and 170 [
13 C]AcAc-derived isotopologue groups for unpolarized, LPS-polarized, and IL-4-polarized macrophages, respectively (Table S1A) . Mitochondrial acetyl-CoA can be exported to the cytosol as citrate through the citrate transporter (CIC)/ATP-citrate lyase system, which contributes to a multitude of pathways ( Figure S1C ). Indeed, intracellular substrate compartmentalization is highly polarization state dependent in macrophages (see also Puchalska et al., 2018) . As observed for TCA cycle intermediates, D-[ 13 C]bOHB-derived 13 C labeling was negligible ( Figure 2B ; Table S1A ).
To assign putative identities to the features labeled by [
AcAc, we applied the PIUMet package (Pirhaji et al., 2016 ; see Table S1A for putative identification of all labeled features). PIUMet supported the putative identification of 68 metabolites in unpolarized macrophages, and 70 in each of the polarized (LPS or IL-4) macrophages ( Figure S2A ). Although the majority (45 identifications) of [ 13 C]AcAc-labeled metabolites were observed in all three macrophage states, the highest number (13 identifications) of uniquely labeled metabolites was observed in IL-4-polarized macrophages ( Figure S2A ). [ 13 C]AcAc-derived carbon was dispersed among amino acids, organic acids, nucleosides, nucleotides, and lipids ( Figure 2C ), indicating that AcAc is also directed into cytoplasmic and other cellular compartment pathways ( Figure S2B ). Mapping of [ 13 C]AcAc-derived putative metabolites into the KEGG (Kyoto Encyclopedia of Genes and Genomes) database revealed major contributions of AcAcderived carbon into amino acid metabolism ( Figure S2C ; Table  S1B ). Thus, conversion of AcAc into acetyl-CoA opens fates (E) Immunoblot for BDH1 protein, migrating at 31 kDa, and actin in protein BMDMs lysate after 24 hr of exposure (positive control: WT mouse liver). The center panel is a high exposure of upper panel blot. NS, non-specific signals.
(F) Labeling of TCA cycle intermediates in LPS polarized macrophages in the presence or absence of FCCP uncoupler (n = 2/group). Data expressed as the mean ± SEM. Significant differences determined by multiple Student's t test with Holm-Sidak correction compared with control. ***p < 0.001; ****p < 0.0001; as indicated. beyond TCA intermediates, many of which are metabolic precursors of these downstream products ( Figure S1C ). Interrogation of [ 13 C]AcAc-labeled metabolites against the BioCyc database revealed, uniquely in IL-4-polarized macrophages, contribution of AcAc to putative glucuronide conjugates that mapped to the chondroitin sulfate (CS) and dermatan sulfate (DS) pathways, proline/arginine degradation, and uridine diphosphate (UDP)-biosynthetic pathways ( Figure 2D ). Selective labeling among macrophage states was evident for numerous features, including labeling of putative UDP N-acetylglucosamine (UDP-GlcNAc) (Figures 2B-2E ; Table S1C ). UDP-GlcNAc is the product of the hexosamine biosynthetic pathway (HBP), and the precursor of N-acetylneuraminic acid (NeuAc; a sialic acid), both of which contribute to the glycoprotein and/or glycosaminoglycan (GAG) pathways. However, the total labeled fraction varied among macrophage polarization states, suggesting polarization-dependent engagement of pathways connected to the HBP (see details in Puchalska et al., 2018) . These data underscore that AcAc-derived carbon has fates beyond the TCA cycle in primary macrophages, with variations that depend on polarization state. Furthermore, the exclusive ability of [ 13 C]AcAc, but not its reduced form D-[ 13 C]bOHB, to contribute to both TCA intermediates and also a large repertoire of additional metabolites raises the hypothesis that mitochondria play a key role in the generation of these downstream cellular metabolites.
AcAc Successfully Competes with Glucose to
Contribute to Diverse Metabolic Pathways in Alternatively Polarized Macrophages As with most mammalian cells, tissue macrophages are simultaneously exposed to multiple substrates that can serve as carbon sources. To determine how macrophages coordinate the use of competing substrates, we first replaced glucose in BMDM culture medium with 10 mM [U- 13 C 6 ]glucose. As expected (Xu et al., 2015) , in LPS-polarized macrophages the relative abundances of the 13 C-labeled PPP intermediates were increased compared with unpolarized or IL-4-polarized states ( Figure S3A ). In contrast, labeling of downstream TCA intermediates in the LPS-polarized state was diminished by 29% for glutamate and 16% for malate (p < 0.001 and 0.01, respectively) (Figures S3B and S1C) similar to [ 13 C]AcAc labeling ( Figure 1A ). We then tested the ability of unlabeled 1 mM AcAc to compete with 10 mM [U-
13
C 6 ]glucose. Because mitochondrial acetyl-CoA decreases glucose-derived pyruvate entry into the TCA cycle by inhibiting pyruvate dehydrogenase (PDH) (Figure S3C ), we expected less incorporation of [ 13 C]glucose-derived acetylCoA into downstream metabolites in the presence of unlabeled AcAc (Cooper et al., 1975) . Indeed, [
13 C]glucose labeling of TCA intermediates in LPS-and IL-4-polarized macrophages was diminished 43%-60% and 33%-44% (all p < 0.001), respectively, in the presence of unlabeled AcAc ( Figure 3A ). These observations suggest preferential oxidation of AcAc over glucose in macrophages irrespective of their polarization state. The metabolic conduit linking mitochondrial conversion of AcAc to acetyl-CoA, via SCOT0thiolase-dependent catalysis, to cytoplasmic metabolism is largely dependent on citrate export from mitochondria via the ATP-citrate lyase-dependent shuttle. However, cytosolic acetoacetyl-CoA synthetase (AACS) also supports the conversion of AcAc to acetyl-CoA (Edmond, 1974; Endemann et al., 1982) . Therefore, we measured the expression of both Aacs and Oxct1 genes in BMDMs and observed unique Oxct1 induction 3-fold by IL-4 ( Figure S4A ). RNA sequencing (RNA-seq) analysis of IL-4-polarized BMDMs revealed a 5-fold increase of Oxct1 mRNA 6 and 24 hr after IL-4 treatment, compared with control ( Figures 3B and 3C ). Accordingly, BMDMs harvested from STAT6 knockout mice (S6KO), which lack the transcription factor mediator downstream of IL-4 signaling, failed to increase Oxct1 expression (Figure 3B ) (Czimmerer et al., 2018; Kapoor et al., 2015) . Analysis of STAT6-chromatin immunoprecipitation (ChIP) datasets revealed IL-4-dependent augmentation of STAT6 occupancy at À43 kb and À1.7 kb relative to the Oxct1 transcription start site (Figure 3C ) (Czimmerer et al., 2018) . Thus, Oxct1 is a potential STAT6 target in alternatively polarized macrophages, suggesting a dynamic role of mitochondrial ketone metabolism in this phenotypic state.
Given the potential role in alternatively polarized macrophages for SCOT, and thus AcAc metabolism, we focused our analysis on the fates of 13 C-labeled substrates in IL-4-polarized macrophages. [U- 13 C 6 ]glucose labeled 249 features in both control and IL-4-polarized cells, with 63 of these exhibiting significant differences in label enrichment ( Figure S4B ). An additional 240 features were uniquely labeled by [U- 13 C 6 ]glucose only in IL-4-polarized cells. Together, these 303 features were mapped to KEGG pathways, which confirmed increased labeling of TCA cycle, pyrimidine, arginine, proline, and purine pathways in alternatively polarized macrophages ( Figure S4C ). In IL-4-polarized macrophages, 71 out of the 446 (16%) features labeled by [U- 13 C 6 ]glucose preferentially incorporated carbon derived from unlabeled AcAc ( Figure 3D ; Table S2 ). To reveal the crosstalk between mitochondrial-dependent ketone metabolism and glucose metabolism, we repeated substrate competition experiments in SCOT knockout (KO) IL-4-polarized macrophages. We confirmed loss of SCOT in BMDMs via immunoblot ( Figure S4D ) and demonstrated preserved canonical responses to LPS and IL-4 polarization in SCOT-KO BMDMs (Figure S4E Figure 3D ; Table S2 ), indicating a primary role of mitochondrial ketone metabolism in the context of mixed substrate exposure. To determine the requirement of mitochondrial AcAc metabolism in alternatively polarized macrophages, the 51 SCOT-dependent competed features were analyzed using PIUMet and MBRole pathway analysis (Tables S2 and S3 ), which revealed CS degradation ( Figure S4H ) similar to our [ 13 C]AcAc datasets ( Figure 2D ). One of the characteristic chemical features of this SCOT-dependent pathway was NeuAc ( Figure 3E ), a terminal sugar residue of glycan chains, which can be synthetized from UDP-GlcNAc ( Figure S4I ). Competition between AcAc and glucose for NeuAc labeling in WT IL-4-polarized BMDMs was abrogated in SCOT KO ( Figure 3E ). While mapping of the 51 SCOT-dependent [ 13 C]glucose-AcAc competing features to KEGG, the TCA cycle was a significant, but not major, contributor among the enriched pathways. Ala, Asp, Glu, Arg, and Pro metabolism (24% of SCOT-dependent features) contribute to the urea cycle, which includes the reaction catalyzed by the canonical alternatively polarized macrophage mediator arginase ( Figure 3F ; Table S3 ). Collectively, in the context of a physiological mix of substrate fuels, alternatively polarized macrophages leverage mitochondrial metabolism of AcAc to generate intermediates in multiple downstream metabolic pathways not directly linked to terminal oxidation.
Mitochondrial Ketone Metabolism in Macrophages Protects against Hepatic Fibrosis
The liver harbors one of the largest resident macrophage populations, Kupffer cells (Guilliams et al., 2016) . Neighboring lobular hepatocytes release signals and metabolites, including glucose and ketone bodies, into the surrounding stroma. Ketogenesis occurs solely in hepatocytes, due to the abundant expression of mitochondrial HMGCS2, and, due to the absence of SCOT expression, hepatocytes do not oxidize the ketone bodies they generate (Orii et al., 2008) . To determine the extent to which mitochondrial metabolism of AcAc supports homeostatic function of tissue macrophages in vivo, we generated macrophagespecific SCOT-KO mice using the LysM-Cre driver and maintained these mice and their littermate controls on a 60% kcal fat diet for 8 weeks ( Figures 4A-4C ). Administration of high-fat diet (HFD) for 8 weeks in WT mice causes hepatic steatosis and mild hepatocyte injury, necrosis, and lobular inflammation but typically does not cause fibrosis (Machado et al., 2015) . SCOT-Macrophage-KO mice exhibited similar plasma total ketone body levels as littermate controls (Figure 4D) , and blood glucose was increased 14% ( Figure 4E ; p = 0.047, n > 10/group) in SCOT-Macrophage-KO mice, although intraperitoneal glucose tolerance tests yielded similar excursions ( Figure 4F ). HFD-fed mice with loss of SCOT in macrophages maintain the same body weight as their littermates (Figure 4G) , and liver steatosis was similar, as determined by oil red O staining ( Figure 4H ) and triacylglycerol quantification ( Figure 4I ). H&E stains of liver sections from SCOT-Macrophage-KO mice revealed comparable histological architecture to littermate controls ( Figure 4J ) and similar density of F4/80 + macrophages ( Figure S5A ).
To reflect variations in hepatocyte-macrophage crosstalk through AcAc exchange, we acquired untargeted metabolomics data derived from liver extracts of SCOT-Macrophage-KO and littermate control mice. Analysis using XCMS online yielded 7,074 total features, of which 238 exhibited a statistically significant R2-fold change ( Figure S5B ; Table S4 ). Among the pathways with the most favorable p values (p < 0.05) were purine metabolism, histone degradation, UDP-GlcNAc/UDP-GalNAc biosynthesis, amino acid degradation, protein glycosylation, ketolysis, and DS degradation. Among the putative dysregulated metabolites was iduronate, whose total ion counts were downregulated 14% in livers of SCOT-Macrophage-KO mice (p < 0.03; Figure 5A ). The identity of iduronate was corroborated using the Compound Discoverer package, which uses natural isotopic distribution to predict compound composition. While no direct relationship was evident between AcAc mitochondrial metabolism in macrophages and diminished static iduronate content in livers of SCOT-Macrophage-KO mice, L-iduronic acid (IdoA) is the major uronic acid within GAGs, and drew our attention due to preferential use of AcAc carbon to amino sugar and NeuAc GAG components within IL-4 polarized BMDMs ( Figures 2D and 3E ). Diverse GAGs, including CS/DS, are composed of polymers of varying amino sugar-uronic acid disaccharides, with varying degrees of sulfation. Macrophages exhibit increased GAG content upon IL-4 polarization, and perturbations in the GAG DS/CS pathways are associated with expansion of extracellular matrix (ECM) that lead to the development of hepatic fibrosis (Decaris et al., 2017; Habuchi et al., 2016; Martinez et al., 2015) . Thus, we next asked if metabolic perturbations of GAG metabolism observed both in cultured macrophages lacking SCOT and liver tissue from animals lacking SCOT in macrophages were linked to hepatic fibrogenesis.
Transcriptional signatures of altered fibrogenesis were evident in livers of SCOT-Macrophage-KO mice, with upregulation of the WT and SCOT-KO BMDM after 24 hr of exposure (n = 4/group). Labeling of the acetyl group derived from mitochondrial acetyl-CoA production from [U- 13 C 6 ] mRNAs for angiogenic factor Vegfc (vascular endothelial growth factor C), mitogen Pdgfa (platelet-derived growth factor A), profibrotic cytokine Il13, and a marker of monocyte recruitment Cd11b ( Figure 5B ). Mediators of immune cell recruitment upon liver injury (Ccl3, Ccl5, Loxl1) were also significantly upregulated in livers of SCOT-Macrophage-KO mice ( Figure 5C ), together with Ym1 and Fizz1 genes, canonical markers of M2 polarization ( Figure 5D ). Arg1 mRNA was unchanged due to the presence in both macrophages and hepatocytes ( Figure S5C ). Tgfb (transforming growth factor b), inflammatory cytokines (Tnfa, Il1b, and Il6) , and oxidative stress markers (Nos2, Hmox1, and Nrf2) were unchanged in livers of SCOT-Macrophage-KO mice (Figure S5C) . However, markers of hepatic stellate cell activation and trans-differentiation into myofibroblasts (Shh, Igfbp5, Acta2) were elevated, suggesting that hepatic stellate cells may also be a target of hepatocyte-derived AcAc ( Figure 5C ). PV, portal vein. Data expressed as the mean ± SEM. Significant differences determined by Student's t test. *p < 0.05; **p < 0.01; ****p < 0.0001; as indicated. Figure 5H ). To confirm the role of locally derived ketogenesis from neighboring hepatocytes, we quantified fibrogenesis in ketogenesis-insufficient mice that are unable to produce ketones in liver (Hmgcs2-targeted antisense oligonucleotides [ASO] ) and maintained these mice on HFD for 8 weeks (Cotter et al., 2014) . These mice fail to express HMGCS2 protein in liver, while gut HMGCS2 protein is preserved, and, irrespective of the presence of SCOT in macrophages, these mice exhibited hypoketonemia in the random fed state ( Figures S6A-S6C ). Untargeted metabolomics studies of livers of ketogenesis-insufficient mice revealed 1,306 features dysregulated >2-fold compared with livers of controls ( Figure 6A ; Table S4 ). Putative features corresponding to iduronate were altered in livers of ketogenesis-insufficient animals, indicating perturbation of the DS/CS pathway (Table S4 ; Figure S6D) . Indeed, Hmgcs2 ASO treatment increased susceptibility to hepatic injury to HFD and increased inflammation and evidence of activated stellate cells (Cotter et al., 2014) . Strikingly, livers of Hmgcs2 ASO-treated animals that also lacked SCOT selectively in macrophages exhibited exuberant inflammation, hepatocyte injury, and profound degradation of hepatic lobular structure ( Figures 6B and 6C ). Picrosirius red staining revealed increased fibrosis in livers of mice lacking both hepatocyte HMGCS2 and macrophage SCOT ( Figures 6C  and 6D ). In summary, ketogenic insufficiency increased lobular fibrosis in both WT and SCOT-Macrophage-KO mice, and loss of SCOT in macrophages predisposed to hepatic fibrosis, independent of Hmgcs2 ASO treatment (>50% increase in fibrosis in both ketogenesis-sufficient and -insufficient states; p < 0.05 for each comparison; Figures 6B-6D ).
To determine whether exogenously administered AcAc recapitulates an anti-fibrotic effect, we maintained WT mice on a fibrogenic diet composed of trans fat, fructose, and cholesterol for 4 weeks (Soufi et al., 2014) . During the fibrogenic interval, either AcAc (10 mmol/g body weight), D-bOHB (10 mmol/g body weight), or vehicle controls were administered every 12 hr via intraperitoneal (i.p.) injections. Pilot kinetic analyses indicated that ketones are completely metabolized within 15 min (AcAc more rapidly than D-bOHB) (Figure S7A) . No significant changes in caloric consumption were observed between ketone-injected groups (Figure S7B) , and body weights were comparable among groups ( Figure S7C ). Blood glucose concentrations at the end of the fibrogenic interval were not altered by ketone injections (Figure S7D ). Because in vitro synthesis of AcAc generates equimolar ethanol, an equivalent ethanol concentration was used as vehicle, and saline was used as a vehicle for D-bOHB. Each dose (AcAc or vehicle) corresponded to <0.5 g ethanol/kg body weight, far below doses used to induce alcoholic hepatitis, and were not associated with systemic signs of toxicity, compared with saline control-treated animals (Gao et al., 2017) . At the end of study, picrosirius red staining of liver sections from AcAc-treated animals showed a 52% reduction of hepatic fibrosis compared with vehicle control animals fed the fibrogenic diet (p = 0.004, n = 7/group; Figures 6E and 6G). Consistent with the divergent metabolic response of cultured primary BMDMs to the two ketone bodies, liver sections from mice injected with D-bOHB exhibited modestly augmented fibrosis in comparison with control animals ( Figures 6F and S7E ). It is possible that low-concentration ethanol dosing enhances the toxic effects of the fibrogenic diet (comparing the two different vehicle groups; Figures 6E and 6F) . Nonetheless, the added presence of AcAc to this vehicle was protective. These results strongly support the contention that mitochondrial macrophage metabolism of either locally produced or systemically administered AcAc, but not D-bOHB, attenuates the hepatic fibrogenic response triggered by elevated nutritional fat.
DISCUSSION
The studies presented herein reveal two primary conclusions. First, an AcAc shuttle released from hepatocytes to neighboring macrophages transduces a mitochondrial metabolism-dependent signal that protects against hepatic lobular fibrogenesis in response to HFD. Second, bOHB is restricted from this shuttle because it cannot be metabolized by macrophage mitochondria. Both findings were generated through the ITUM platform, in which stable isotope tracing analysis was fully untargeted. Multiple analyses revealed a strong molecular metabolite candidate Data expressed as the mean ± SEM. Significant differences determined by Student's t test. Correlation determined by fitting within polynomial (second order) or linear regression. *p < 0.05; **p < 0.01; ***p < 0.001; as indicated. as a potential conduit for AcAc carbon in alternatively polarized macrophages, the GAGs. Indeed, revelation of macrophage GAG metabolism stimulated the hypothesis that a hepatocytemacrophage AcAc shuttle regulates hepatic lobular fibrosis, which was further supported by genetic mouse models. A protective effect of AcAc was observed in animals in the energy-replete fed state and did not require provocation by fasting-induced ketogenesis, while exogenous AcAc (and not bOHB) was also protective from diet-induced hepatic lobular fibrosis. Thus, analogous to the lactate shuttle posed in the CNS, or the branched chain amino acid metabolite 3-hydroxyisobutyrate in muscle, liver is a highly plausible organ in which a local AcAc shuttle could exist (Brooks, 2018; Jang et al., 2016; Liu et al., 2017b) . Our observations also indicate that substrate fuel selection, availability, and partitioning directly influence polarized macrophage function (Saha et al., 2017; Verdeguer and Aouadi, 2017) . While the observations herein are consistent with the benefits of nutritionally provoked ketogenesis in both human and animal models of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), they indicate that independent effects of AcAc versus bOHB may influence the benefits of ketosis (Mardinoglu et al., 2018; Pawlak et al., 2015) . Independent effects of ketones are important to consider due to physiological variations in the AcAc/bOHB ratio secreted by the liver (Krebs and Hems, 1970; McGarry and Foster, 1971) . Responses to individual ketone bodies may vary and depend on target cell type and ketogenic rate (Puchalska and Crawford, 2017) . Indeed, bOHB has been linked to anti-inflammatory responses in macrophages (Rahman et al., 2014; Youm et al., 2015) , while AcAc can promote inflammatory signaling and oxidative stress (Jain et al., 2002; Kanikarla-Marie and Jain, 2015; Kurepa et al., 2012) . Macrophages integrate numerous signals, and intact bOHB macrophage signaling could explain the lack of inflammation in fibrogenic livers of SCOT-Macrophage-KO mice, while superimposed HMGCS2 deficiency (which limits, but does not eliminate ketogenesis; Cotter et al., 2014; d'Avignon et al., 2018) yields both inflammation and fibrosis. However, recurrent boluses of high D-bOHB concentrations may provoke toxic responses in non-macrophages. Indeed, high-concentration bOHB activates pro-inflammatory and oxidative stress in calf hepatocytes and in other cell types (Meroni et al., 2018; Shi et al., 2014) . Thus, tissue responses to ketone bodies require attentiveness to (1) distinct cell type responses within a tissue; (2) the delivered AcAc/bOHB ratio (including, but not limited to, mitochondrial redox potential effect); (3) total ketone body concentration and kinetics; and (4) augmenting or competing signals. Exogenous ketone preparations for prospective therapeutic or health-maintaining ends, including ketone esters, requires diligent attention to all of these principles.
While AcAc contributes to sterol and fatty acid biosynthesis through cytosolic AACS in extrahepatic cell types, the contribution of AcAc through mitochondrial (SCOT-dependent) routes to cytosolic pathways has not been previously demonstrated (Hasegawa et al., 2012; Yamasaki et al., 2016) . Here (and in Puchalska et al., 2018) we demonstrate that AcAc-derived carbon, in an SCOT-dependent manner, contributes to GAG/glycoprotein/proteoglycan canonical metabolic pathways via labeling of UDP-GlcNAc/GalNAc or NeuAc in macrophages. Indeed, substrate selection and downstream metabolism may be equally important to support anabolic pathways and provide covalent modifiers for post-translational modifications, rather than fulfilling obligate cellular energy requirements (Schoors et al., 2015; Wong et al., 2017) .
The composition of GAGs/ECM is remodeled under dietinduced metabolic disorders, hypercholesterolemia, diabetes, and cirrhosis, and while exogenous administration of purified GAGs ameliorates inflammation, oxidative stress, and fibrogenesis, decreases in GAG synthesis are fibrogenic (Campo et al., 2004; Liu et al., 2017a) . The cellular component of GAGs is remodeled during monocyte-macrophage differentiation and depends on polarization (Chang et al., 2012; Martinez et al., 2015) . While the primary drivers of ECM expansion and fibrosis in liver are hepatic stellate cells, macrophages produce proteoglycans (i.e., protein-GAG complexes) and ECM-modifying enzymes that may configure the fibrogenic cascade (Laskin et al., 1991; Matsubayashi et al., 2017; Winberg et al., 2000) . GAG species may exert opposing actions on tissue fibrogenesis, with some exerting inhibitory roles in tissue fibrosis (Chen and Birk, 2013; Vogel et al., 1984) . These results support a model in which hepatocyte-derived AcAc represents a safe signal to neighboring macrophages in a manner that is critical for GAG homeostasis in the fed state.
Hepatic fibrosis develops in response to numerous insults, including persistent overnutrition, genetic abnormalities of lipid metabolism, viral infection, toxins, ethanol, and autoimmune reactions, all of which lead to chronic immune activation that results in excessive production of ECM (Diehl and Day, 2017; Koyama and Brenner, 2017) . Additionally, stimuli derived from injured hepatocytes, tissue macrophages, and/or endothelial cells activate hepatic stellate cells and promote their differentiation to myofibroblasts (Friedman, 2008; Pellicoro et al., 2014) . Inflammation-independent hepatic fibrosis has been observed in select circumstances (e.g., hemochromatosis), and thus, while inflammation is a key trigger, it is not absolutely required to induce a fibrogenic cascade. While the mRNA encoding TGFb was not augmented in our studies, it is possible that metabolic cues sensed by tissue macrophages operate through downstream mechanisms. Indeed, we observed activation of stellate cell, angiogenic factors, mediators of hedgehog pathway, and metabolomics signals consistent with cell proliferation, amino acid degradation, protein glycosylation, the HBP, and DS/CS synthesis.
Metabolic and histopathological features influenced by hepatic tissue macrophages could represent the effects on resident and/or recruited macrophages, as myeloid cells throughout the body lack SCOT in the LysM-Cre-driven SCOT-Macrophage-KO model. Resident (fetal liver/yolk sac-derived, F4/ 80
Hi Cd11b
Lo/Int ) macrophages in the liver (Kupffer cells) may indeed harbor important functional differences compared with recruited BMDMs (F4/80
Lo/Int /Cd11b Hi ) (Mowat et al., 2017 (Mederacke et al., 2013; Xu and Kisseleva, 2015) . The likelihood that an AcAc shuttle's coordination of hepatic fibrogenesis signals first through lobular macrophages is supported by a lack of phenotype in adipose tissue of SCOT-Macrophage-KO mice. Thus, extrahepatic alteration of myeloid cells and/or secretion of adipokines are likely not significant contributors to hepatic fibrogenesis in the SCOT-Macrophage-KO mice model (Adolph et al., 2017) . Finally, the presence of abundant desmin + /SCOT + cells in livers of fibrogenic SCOT-Macrophage-KO mice suggests that the effects of AcAc on these effector cells are first modulated through local LysM-Cre + cells. Thus, although trans-differentiation of hepatic stellate cells is probably promoted by Kupffer cell macrophages that lack SCOT, future studies need to segregate the roles of mitochondrial ketone metabolism among cell types, and also between AcAc versus D-bOHB among different immune and fibrosis effectors in steatohepatitis amelioration. Due to the highly conserved wound-healing process leading to fibrogenesis (Dobie et al., 2015; Pellicoro et al., 2014) , our observations in the liver may be relevant in other organs, although the liver is especially poised to leverage ketones due to their abundant production in neighboring hepatocytes, even in the fed state.
Limitations of Study
ITUM highlights the contribution of hepatocyte-derived AcAc into diverse macrophage metabolic pathways beyond the TCA cycle, including the GAG cytosolic synthetic pathway. Quantitative measures of AcAc's dynamic influence over substrate-product relationships in the turnover of diverse GAG species in hepatic macrophages, and in liver tissue, remain to be determined. In addition, future studies will resolve quantitative shifts in GAG species diversity and the associated impact on hepatic fibrogenesis.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animal Models and Animal Model for Primary Cells
Primary macrophage cultures were obtained from 9-to 16-week old male and female C57BL/6NJ sub-strain hybrid mice carrying the Oxct1 flox/flox allele previously described (Cotter et al., 2013) . This allele encodes SCOT and is functionally wild type with no obvious phenotype in carriers. Germline ubiquitous SCOT-KO mice are fully lethal in the neonatal period. To generate adult whole-body SCOT knockout mice, Oxct1 flox/flox animals were crossed with the ubiquitously expressed Cre/ESR1 fusion [B6.Cg-Tg(CAG-cre/Esr1*) 5Amc/J, stock number 004682, Jackson Laboratory], and 6-week old Cre-positive offspring and their Cre-negative littermate controls were subjected to a 17-day tamoxifen (Cayman Chemical) injection regimen at 20 mg/kg animal weight. A two-week washout period after the final injection was allowed for pre-existing SCOT protein turnover (Schugar et al., 2014) . These animals are designated as 'SCOT-KO' and 'WT', respectively, where they were used in the experiments described below. Successful KO was confirmed via Western blot for SCOT protein in heart and skeletal muscle and via lack of [ 13 C]AcAc oxidation in bone marrow-derived macrophages (BMDM).
Macrophage specific SCOT-KO mice were generated by successive rounds of breeding of Oxct1 flox/flox mice to the LysM-Cre strain from Jackson Laboratories (B6.129P2-Lyz2tm1(cre)ifo/J, stock number 004781, Jackson). Genotyping primers can be found in Table S5 . To create HMGCS2 knockdown mice, ASO treatment was initiated in six week-old mice by injecting (25 mg/kg) of Hmgcs2-targeted ASO (Ionis 191229; 5 0 -CTGTTTGTCACTGCTGGATG) or scrambled sequence control ASOs (Ionis 141923; 5 0 -CCTTCCCT GAAGGTTCCTCC) biweekly for 4 weeks prior to initiation of high fat diet, and were continued through high fat diet administration.
To study the role of exogenously-delivered ketone bodies in liver fibrosis, 7 week-old male C57BL/6J mice (stock number 000664) were purchased from Jackson Laboratories.
Mice were maintained on a standard low-fat chow diet (2016 Teklad global 16% protein rodent diet), 8 weeks on high fat diet (D12492; Research Diets; 60% kcal fat, 20% protein, 20% carbohydrate) or 4 weeks on a hepatic fibrogenic diet [D09100301; Research Diets: 40% kcal fat, predominantly trans fat (trans oleic and trans linoleic acids), 20% kcal fructose (total carbohydrate, 40% kcal), and cholesterol (2% w/w)], and given autoclaved water ad libitum. Lights were off between 1900 and 0700 in a room maintained at 22 C. All animal experiments were performed through protocols formally approved by the Institutional Animal Care and Use Committees at Sanford Burnham Prebys Medical Discovery Institute-Lake Nona and the University of Minnesota.
Bone Marrow-Derived Macrophage (BMDM) Isolation and Culture Animals were sacrificed by cervical dislocation prior to harvest of the femurs and tibia of both legs. The marrow was flushed out using cold Ca 2+ and Mg 2+ -free Hank's buffered salt solution (HBSS) delivered through 3-mL syringes and 23-to 27-guage needles, respectively. The pooled marrow from one animal was dispersed using a P1000 micropipette, and debris was allowed to settle before the suspension was transferred into fresh tubes and centrifuged. The resulting pellet was resuspended in BMDM differentiation media (RPMI (Thermo Fisher, includes 10 mM glucose) with 10% L929 conditioned media, 10% fetal bovine serum (FBS), 2 mM glutamine, 10 U/mL penicillin/streptomycin) and distributed into tissue culture plates at an average density of one animal into 100-cm 2 total surface area for growth. Fresh differentiation media was added two days after isolation. At day 4, exhausted media and non-adherent cells were aspirated from the plates, cells were washed with pre-warmed HBSS, and fresh media was added. After a second media change on day 6, mature macrophages were used on day 7 for labeling and treatment studies. L929 conditioned media was generated by culturing L929 cells to confluence over the course of 4-5 days in 10% FBS supplemented DMEM (50 mL per 175 cm 2 flask), after which the media was removed, filtered, and aliquoted for frozen storage. In all studies, cells isolated from a single animal were counted as a single replicate unless otherwise indicated.
METHOD DETAILS
Synthesis of AcAc
AcAc was synthetized by a base-catalyzed hydrolysis of ethylacetoacetate (ethyl-AcAc): 8 mL of 1 M NaOH was added to 1 mL ethylAcAc while stirring at 60 C. After 30 min, the reaction was neutralized with 50% HCl to pH 8, and the concentration of AcAc was determined with a colorimetric enzyme-based total ketone body (TKB) assay (Wako) prior to aliquoting and storage at -80 C.
Exogenous Delivery of Ketone Bodies
To study the role of exogenously-delivered ketone bodies in liver fibrosis, 7 week-old male C57BL/6J mice were acclimatized for one week, and then maintained on fibrogenic diet for 4 weeks and injected twice daily i.p. (10 mmol/g body weight) with AcAc, D-bOHB or their vehicles. Because the AcAc synthesis reaction generates equimolar quantities of ethanol and AcAc and no further purification of AcAc was undertaken, ethanol was used as a vehicle for AcAc injections: 250 mL i.p. equimolar (=$5%) ethanol. Sodium D-bOHB (Santa Cruz, pH corrected to 7.0, 250 mL i.p.), and equimolar NaCl was used as a vehicle control for D-bOHB mice (250 mL). C57BL/6J mice were used for the exogenous ketone (compared to vehicle control) mice fed fibrogenic diet fed for four weeks, receiving injections every 12 h.
Labeling of Cultured Primary Cells by Stable Isotopes
BMDMs were incubated in glucose-and serum-free DMEM containing 2 mM glutamine for 1 h prior to the introduction of 13 C-labeled substrates (Cambridge Isotope Laboratories). Uniformly labeled sodium D-[U-13 C]bOHB (1 mM), or [U-13 C]AcAc (1 mM) were added to DMEM containing 10 mM glucose and 2 mM glutamine. For experiments using exogenously added [U-13 C]glucose (10 mM), glucose-free DMEM was used. Uniformly labeled AcAc was generated by a base-catalyzed hydrolysis of [1,2,3,4-13 C 4 ] ethylacetoacetate using same protocol as for unlabeled AcAc. EtOH was added to control experiments at a concentration equal to that of the highest amount of AcAc used due to the equimolar quantity of EtOH in the sample after AcAc synthesis. Labeling experiments were done for 6h and/or 24h, at which points the media was removed and cells were processed using the metabolite extraction method described below. To induce M1 or M2 polarization in BMDMs, lipopolysaccharide (LPS, Millipore) or IL-4 (PeproTech), respectively, were added to a final concentration of 25 ng/mL to the labeling media at the same time the media was introduced to the cells after their 1 h incubation in glucose-and serum-free DMEM. All drug (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP, Enzo Life Sciences) and substrate treatments (AcAc) were introduced simultaneously, with the labeling media, macrophage polarizing agents, and maintained for either 6 h or 24 h.
Targeted and Untargeted LC/MS Analysis
Liquid chromatography was performed on a Dionex Ultimate 3000 RSLC using a Phenomenex Luna NH 2 column (100 mm x 1 mm, 3 mm particle size) for untargeted metabolomics surveys. We used hydrophilic interaction liquid chromatography (HILIC) mode, with the following mobile phase compositions: A = 95% H 2 O, 5% ACN, 10 mM NH 4 OAc/ NH 4 OH, pH 9.5; B = 95% ACN, 5% H 2 O, 10 mM NH 4 OAc/ NH 4 OH, pH 9.5. Unless otherwise stated, the extracts were usually separated using binary gradient 75-0% B for 45 min, then 0% B for 12 min, and 75%B for 13 min at 50 mL/min. [ 13 C]glucose analysis of SCOT WT and SCOT KO IL-4 polarized BMDMs, and tissue extract analysis were performed with an extended gradient starting at 100% B for 5 min, 100-0% of B for 45 min, 0-100% of B for 7 min, and 100% B for next 13 min. Column temperature was maintained at 30 C, and injection volume was 4 mL. Citrulline quantification in conditioned media was performed using isocratic elution of 75% B for 6 min; flow rate 50 mL/min; column temperature at 30 C; and injection volume 4 mL. Prior to the analysis, to the conditioned media, 15 mM alanine was added as an internal standard. Mass spectrometry (MS) was performed on a Thermo Q Exactive Plus with heated ESI source. The MS was operated mostly in negative mode with exception of citrulline analysis where positive mode was applied. MS resolution was set to 70,000 and the AGC target to 3e 6 ions with a maximum injection time of 200 ms. The mass scan range for extract analysis was 68-1020 m/z, while for citrulline, 80-200 m/z. In targeted analysis, full scan mode was used with the addition of an inclusion list of the ions of interests. The resolution was set to 35,000, AGC target to 2e 5 ions with a maximum injection time of 100 ms, isolation width 2.0 m/z, and fixed normalized collision energy 35 (arbitrary unit). Common ESI parameters were: auxiliary gas 10, sweep gas 1, spray voltage -3 kV, capillary temperature 275 C, S-lens RF 50, and auxiliary gas temperature 150 C. The sheath gas flow for extract analysis was set to 35 (arbitrary unit).
LC/MS Data Processing
Data from liver metabolomics and stable isotope tracing untargeted metabolomics (ITUM) experiments (.RAW files) were converted to mzXML format using MSConvert with the vendor peak-picking option selected, and processed using XCMSonline or X 13 CMS R package as described previously (Cotter et al., 2014; Huang et al., 2014; Mahieu et al., 2016a Mahieu et al., , 2016b . The .RAW data files were uploaded for analysis using Compound Discoverer (ver. 2.1). Liver metabolomics data were uploaded to XCMSonline, and analyzed based on the method ''HPLC / Orbitrap -HPLC with $60 min gradient / Orbitrap'' available online with modifications. The feature detection parameters were 5 ppm, peak width interval to 10-180 min, integration method to 2, and prefilter intensity to 500. Retention time correction was changed to 0.5 prof Step (in m/z), while alignment bw to 30 and mzwid to 0.025. Peaks with fold change greater than 2 were selected, with median fold change normalization option. For Compound Discoverer 2.1., analysis was performed based on the ''untarg. Metabolomics w Statistics Detect Unknowns w Mapped Pathways and ID using online databases'' workflow with modifications. To select the spectra, 60-1500 Da m/z scan was used with intensity threshold 500, and highest charge 4. We applied adaptive alignment curve method with maximum 4 min RT shift and 5 ppm mass tolerance. Unknown compounds were detected with 5 ppm mass tolerance, and grouped with 1 min RT tolerance. Maximum of 10 compounds per feature were predicted and searched against ChemSpider and KEGG database with 5 ppm mass tolerance. For ITUM X
13
CMS base analysis, the data was processed using R studio where the XCMS (v. 1.4) package was used to pick chromatographic (method = 'centWave', ppm = 2.5, peakwidth = c(20, 180)) peaks and align retention time (bw=10, mzwid=0.015, retention time correction method = 'obiwarp') across samples within an experiment. X 13 CMS (v.1.4) was used on the output to extract isotopologue groups. The parameters used for X 13 CMS are RTwindow = 10, ppm = 5, noiseCutoff = 10000, intChoice = ''intb'', alpha = 0.05 within getIsoLabelReport().
Identification of Metabolites Detected in LC/MS and Pathway Analysis
The identity of a subset of metabolites was confirmed by matching the retention time and MS/MS of standard compounds run using identical chromatographic separation conditions (Table S5 ). Another subset was assigned putative identifications based on (i) match of unlabeled accurate masses in the Metlin database, (ii) molecular formulas and structures, which could produce the observed number of carbon labels in a biological context, and (iii) predicted retention time based on chemical similarity to standard compounds (Table S5 ). Pathway analysis was performed with the aid of PIUMet analysis (Pirhaji et al., 2016) and MBRole web-based application (Lopez-Ibanez et al., 2016) . For PIUMet analysis the files containing input m/z values, polarization modes, and -log of p values were uploaded for the analysis. For labeled compound found just in one macrophage polarization state, the p value was assumed to be 0.05. For MBRole analysis, the putative identification were assigned based on the hmdb.ca (Wishart et al., 2013) database search from PIUMet output. HMDB output was mapped using MBRole against mouse KEGG or BioCyc database. Holm-Sidak correction when compared to control. * p < 0.05; **, p < 0.01 ***; p < 0.001; ****, p < 0.0001; *****, p < 0.00001, as indicated. 
